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Abstract We report that short-chain ceramide (Cer), C2- and 
C6-Cer, were immediately glycosylated and finally converted to 
short-chain Cer GM3 in B16 melanoma cells. By addition of 
either C~- or C6-Cer to a cell culture of B16 melanoma in the 
presence of [14ClGal, the radiolabeled precursor, was incorpo- 
rated into each of two novel glycosphingolipids (GSLs) within 30 
min along with synthesis of normal GSLs. These novel GSLs were 
identified as C2-, C6-Cer cerebrosides and C2-, C6-Cer GM3, 
respectively. In comparison with C2-Cer, C6-Cer was found to be 
much more efficiently converted to the GSLs, whereas no glyco- 
sylated sphingosine was detectable when it was added in place of 
short-chain Cer. 
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1. Introduction 
Ceramide (Cer), the common lipid backbone of sphingolip- 
ids, has been proved to act as an intracellular second messenger 
and cell regulatory molecule in numerous tudies using short- 
chain synthetic Cer with improved cell-permeability, instead of 
natural  Cer. For  example, C2- and C6-Cer have been shown to 
induce cell differentiation [1] and programmed cell death [2], to 
mediate EGF receptor phosphorylat ion [3] and endocytosis [4], 
and to inhibit neutrophi l  superoxide formation and calcium 
influx [5]. However, there have been very few reports about the 
intracellular metabol ism of these synthetic short-chain Cer. 
Lipsky and Pagano studied sphingolipid metabol ism in cul- 
tured fibroblasts employing a fluorescent Cer analogue, C6- 
NBD-Cer  [6]. They reported that the C6-NBD-Cer was con- 
verted to NBD-labeled sphingomyelin and NBD-labeled gluco- 
sylceramide (GlcCer), but never to more complex glycosphin- 
golipids (GSLs). When [3H]Cz-Cer was added to a culture of 
HL-60 cells, the labeled C2-Cer was incorporated promptly into 
the cells but not metabolized to sphingosine (Sph), and substan- 
tially all Cer were detected as the intact forms even after pro- 
longed incubat ion at 37°C [1]. It was indicated that only a small 
percentage of the label (2.8%) was converted to sphingomyelin 
and not to GSLs [1]. In contrast o these reports, we found that 
C2- and C6-Cer were immediately glycosylated and finally con- 
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verted to short-chain Cer GM3 in B16 melanoma cells when the 
Cer was added in the presence of [14C]Gal. This paper describes 
the identification of novel GSLs with short-chain Cer which 
were synthesized from corresponding short-chain Cer as prim- 
ers and the kinetics of their intracellular formation. 
2. Materials and methods 
2.1. Materials 
Sph, C2-Cer and C6-Cer were purchased from Matreya, USA 
[14C]Gal was obtained from DuPont-New England Nuclear, USA and 
TLC plates (silica gel 60) were from Merck, Germany. fl-Galactosidase 
(from jack bean) and fl-glucosidase (from sweet almond) were from 
Seikagaku Co., Japan, and Funakoshi Co., Japan, respectively. D-Ga- 
lactonic acid y-lactone, psychosine and Triton X-100 were from Sigma, 
USA. D-Glucono-y-lactone, decane and C2-Cer GM3 were from Wako 
Co., Japan. Endoglycoceramidase (EGCase) was prepared from the 
culture fluid ofRhodococcus sp. M-777 [7 9] or purchased from Takara 
Shuzo Co., Japan. Sphingolipid ceramide N-deacylase was prepared 
from the culture fluid of Pseudomonas sp. TK-4 [10]. 
2.2. Cell culture and metabolic labeling 
B16 melanoma cells were grown in MEM medium supplemented 
with 10% fetal calf serum (FCS) at 37°C in a humidified 95% air/5% 
CO2 incubator. For the labeling experiments, 1 × 105 cells were seeded 
in 24-well microplates and precultured for 16 h to allow the cells to 
attach to the plate. After preincubation, the medium was replaced with 
200 ~1 of fresh MEM medium supplemented with 5% FCS containing 
1 ~Ci [14C]Gal and incubated for the time indicated. 
2.3. Addition of synthetic short-chain Cer and Sph 
Sph, C2-, or C6-Cer was first dissolved in ethanol/decane (98 : 2 v/v). 
The solution was added to the medium in a tube and mixed well with 
a Vortex mixer. The final concentration f the ethanol~lecane solution 
in the medium was 0.5% [11]. 
2.4. Extraction of GSLs and analysis by TLC 
B16 cells were harvested by centrifugation (800 rpm × 10 min) and 
washed with PBS. The cells were suspended in 750/~1 of i-propanol/ 
hexane/water (55:35:10 v/v), subjected to sonication for 20 min [12] 
and centrifuged at 13,000 rpm for 5 min. The supernatants obtained 
were dried, dissolved in 20/11 of chloroform/methanol (2:1 v/v) and 
applied to a TLC plate, which was then developed with solvent A 
(chloroform/methanol/0.2% KCI (5:4 : 1 v/v)) or solvent B (chloroform/ 
methanol/0.2% CaC12 (60 : 40 : 9 v/v)). Each radioactive GSL separated 
on the TLC plate was analyzed and quantified by a BAS1000 image 
analyzer (Fuji Film, Japan). 
2.5. Preparation of standard short-cha& Cer GSLs 
C2-Cer cerebroside was prepared from psychosine according to the 
method escribed previously [13]. C6-Cer GM3 and C6-Cer cerebroside 
were prepared from lyso-GM3 and psychosine, respectively, by the 
method as shown in ref. [14]. Lyso-GM3 was prepared from GM3 by 
digestion with sphingolipid ceramide N-deacylase [10]. 
2.6. Identification of short-chain Cer GSLs from B16 cells using a 
specific glycosidase 
GSLs with short-chain Cer were scraped from the TLC plate and 
suspended in 1 ml of chloroform/methanol (2 : 1 v/v), followed by son- 
ication for 1 h. After centrifugation at 12,000 rpm for 5 min, the 
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Fig. 1. TLC analysis of short-chain Cer GSLs in B16 cells. (A) Conver- 
sion of exogenously added short-chain Cer to short-chain GSLs. Lane 
1 = control; lane 2 = C2-Cer; lane 3 = C6-Cer. (B) Effect of Sph on de 
novo GSL synthesis. Lane 1 = control; lane 2 = Sph 5/IM; lane 3 = Sph 
10/IM. Details are given in the text. 
supernatants were dried and dissolved in 20 fll of 10 mM acetate buffer, 
pH 6.0, containing 0.2% Triton X-100. For identification of GM3 with 
short-chain Cer, 10 ,ul of EGCase (5 mU) was added and incubated at 
37°C overnight. For cerebrosides with short-chain Cer, 10 fll of either 
fl-galactosidase (200 mU) or fl-glucosidase (200 mU) was added instead 
of EGCase. Glycosidase inhibitor was included in the reaction at a 
concentration of 5 mM; D-galactonic acid ?'-lactone was used for the 
fl-glucosidase reaction to inhibit any contaminating fl-galactosidase 
and D-glucono-y-lactone to inhibit any fl-glucosidase. After incubation 
at 37°C overnight, the reaction mixture was dried, dissolved in 20 fll 
of 50% methanol and applied to a TLC plate, which was then developed 
with solvent A. Each radioactive GSL separeted on the TLC plate was 
analyzed by a BAS1000 image analyzer (Fuji Film, Japan). 
3. Results 
3.1. Identification of novel GSLs with short-chain Cer 
When B16 melanoma cells were cultivated in MEM medium 
containing C2- or C6-Cer at a concentrat ion of 5 ,uM in the 
presence of 1 flCi [t4C]Gal for 2 h, two spots derived from each 
short-chain Cer were detected along with normal GM3 and 
cerebrosides by the image analyzer (Fig. 1A; A,B in lane 2; C,D 
in lane 3). In order to identify these novel radioactive spots, 
each of them was scraped from the TLC plate separately and 
extracted with chloroform/methanol  (2:1 v/v). The Rr of spot 
B on TLC was identical to that of standard C2-Cer GM3 using 
two different solvent systems (R¢ 0.36 in solvent A; Rf 0.21 in 
solvent B), and that of spot D was standard C6-Cer GM3 (Rf 
0.41 in solvent A; Rf 0.26 in solvent B). Furthermore,  an en- 
doglycoceramidase (EGCase), which cleaves the glycosidic 
linkage between oligosaccharide and Cer of various GSLs [7-9], 
was used to confirm the identification of the novel GSLs form- 
ing spots B and D. As shown in Fig. 2A, radioactive oligosac- 
charides were released from the novel GSLs as well as normal 
GM 3 by the action of EGCase, and all of these oligosaccharides 
had the same Rr as that of sialyllactose. These oligosaccharides 
were further hydrolyzed by neuraminidase from Arthrobacter 
ureafaciens to produce the radioactive spots corresponding to 
lactose (data not shown). These results indicated that the sugar 
chains of the novel GSLs forming spots B and D were both 
NeuAc-lactose. It was thus concluded that spots B and D were 
GM3 having C2- and C6-Cer , respectively. 
To identify the radioactive spots A and C, fl-glucosidase and 
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Fig. 2. Identification of short-chain Cer GSLs using specific glycosidases. (A) Identification of short-chain Cer GM3 by EGCase. Lane 1 = GM3; 
lane 2 = GM3 + EGCase; lane 3 = GSL isolated from spot D; lane 4 = GSL isolated from spot D + EGCase; lane 5 = GSL isolated from spot B; 
lane 6 = GSL isolated from spot B + EGCase. (B) Identification of short-chain Cer cerebrosides by exoglycosidase. Lane 1 = cerebroside; lane 
2 = cerebroside +fl-glucosidase; lane 3 = cerebroside +fl-galactosidase; lane 4 = GSL isolated from spot C; lane 5 = GSL isolated from spot C + fl- 
glucosidase; lane 6 -- GSL isolated from spot C + fl-galactosidase; lane 7 = GSL isolated from spot A; lane 8 -- GSL isolated from spot A + fl- 
glucosidase; lane 9 = GSL isolated from spot A + fl-galactosidase. MS = monosaccharide. Details are given in the text. 
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Fig. 3. Kinetics for intracellular formation of short-chain Cer GSLs in B16 cells. (A) Time course for de novo synthesis of short-chain Cer GSLs. 
The results are averages obtained from two different experiments. [] = C2-Cer cerebroside; • -- C2-Cer GM3; o = C6-Cer cerebroside; • = C6-Cer 
GM3. (B) Effects of concentration of short-chain Cer on de novo GSL synthesis. The results are averages obtained from two different experiments. 
zx = cerebroside; • = GM3; [] = C2-Cer cerebroside; o = C6-Cer cerebroside; • = C2-Cer GM3; • = C6-Cer GM3. PSL = photo-stimulated lumines- 
cence. Details are given in the text. 
fl-galactosidase were used with specific inhibitors as described 
in section 2. As shown in Fig. 2B, GSLs forming spots A and 
C were hydrolyzed by both fl-glucosidase and fl-galactosidase 
to produce monosaccharides (lanes 8,9 and 5,6), whereas nor- 
mal cerebroside of B 16 cells was hydrolyzed by fl-galactosidase 
(lane 3) but was completely resistant o fl-glucosidase (lane 2). 
Furthermore, Rr of spot A on TLC was shown to be identical 
to that of standard C2-Cer cerebroside (Rr 0.66 in solvent A; Rr 
0.58 in solvent B), and that of spot C was standard C6-Cer 
cerebroside (R r 0.74 in solvent A, Rr 0.66 in solvent B) using two 
different solvent systems. These results indicated that the nor- 
mal cerebroside detected in this experiment was GalCer, and 
GSLs forming spots A and C were a mixture of GlcCer and 
GalCer with respective short-chain Cer. This result may suggest 
that short-chain Cer GlcCer was converted more slowly to 
short-chain Cer LacCer in comparison with the normal GlcCer, 
and thus short-chain Cer GlcCer could be detected transiently 
on TLC. It should be noted that in B16 cells no extension of 
sugar chains from GalCer could be occurred and therefore 
GalCer was apparently enriched. No novel GSLs were appar- 
ent on TLC when sphingosine (Sph) was added to a culture of 
B16 cells at a concentration of either 5 or 10/zM instead of 
short-chain Cer (Fig. 1B, lanes 2,3). Interestingly, however, de 
novo synthesis of cerebrosides and GM3 was distinctly in- 
creased when Sph was added. As reported previously [1], we 
also detected the C2-Cer sphingomyelin when C2-Cer was added 
to cultured B16 melanoma cells in the presence of [~4C]choline 
instead of [14C]Gal (date not shown). 
3.2. KineticsJor intracellular formation of short-chain Cer GSLs 
In order to investigate the time course of the de novo synthe- 
sis of short-chain Cer GSLs, B16 melanoma cells were grown 
at 37°C for the indicated time in MEM medium containing 
5/zM short-chain Cer in the presence of 1 /.tCi ['4C]Gal. C2-, 
C6-Cer cerebrosides and C2-, C6-Cer GM3 appeared within 30 
min and increased gradually in a time-dependent manner (Fig. 
3A). The de novo synthesis of all short-chain Cer GSLs reached 
a plateau within 2 h except for C6-Cer GM3, which increased 
continuously even up to 6 h in the same manner as normal 
GM3. In comparison with C2-Cer, C6-Cer was found to be 
much more efficiently converted to short-chain Cer GSLs; de 
novo synthesis of C6-Cer GM3 and C6-Cer cerebroside at 3 h 
after addition of short-chain Cer was about 6.8-fold and 4.1- 
fold, respectively, in comparison to that of the C2-Cer counter- 
parts (means of 5 independent experiments). 
To clarify the effects of concentration of short-chain Cer on 
de novo synthesis of GSLs, B16 melanoma cells were cultivated 
in MEM medium containing increasing amounts of synthetic 
Cer in the presence of 1 /.tCi [14C]Gal for 2 h. The de novo 
synthesis of short-chain Cer GM3 increased gradually in a 
dose-dependent manner up to 25/tM, while that of short-chain 
Cer cerebrosides increased rapidly from the concentration of 
5/.tM (Fig. 3B). At a concentration of 10 ~M, the synthesis of 
short-chain cerebrosides greatly exceeded that of normal cere- 
brosides. It was noteworthy that the de novo synthesis of nor- 
mal GSL was little affected by the addition of short-chain Cer. 
4. Discussion 
Several lines of evidence have indicated that short-chain Cer, 
which could mimic natural Cer, evoke various physiological 
effects in different ypes of cell [1-5]. The most important find- 
ing of this study was that short-chain Cer could be converted 
to short-chain gangliosides GM3 in intact cells. This may indi- 
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cate that the physiological effects of short-chain Cer reported 
so far might be attributable in part to the formation of short- 
chain Cer gangliosides. It should be clarified whether short- 
chain Cer GM3 can be converted to more complex gangliosides 
using other cell lines, since the B16 melanoma cells used in this 
study do not possess a GM2-synthetic enzyme, and the final 
product of ganglioside is GM3. 
It has been reported that a fluorescent Cer analogue C6- 
NBD-Cer is quickly incorporated into the plasma membrane 
at 2°C and transported to the Golgi apparatus at 37°C, where 
C6-NBD-Cer is converted to C6-NBD-Cer sphingomyelin or 
C6-NBD-Cer GlcCer but not to more complex GSLs [6]. These 
data are therefore in conflict with our observation that C6-Cer 
were quickly converted to C6-Cer GM3. One is forced to con- 
clude that the incomplete xtension of sugar chains observed 
in [6] is due to the attachment of a fluorescent molecule (NBD) 
to a Cer, and not to the length of the fatty acid chains. How- 
ever, N-acyl chain or at least an N-acetyl group bound to the 
Sph moiety would be necessary for intracellular glycosylation, 
since this study showed that Sph could not be directly glycosyl- 
ated in B16 (Fig. 1B). It is also noteworthy that a longer acyl 
chain (C6 > C2) in a Cer molecule led to better conversion to 
GM3 (Figs. 1A,3A). 
It has been reported that exogenously added short-chain Cer 
have negative ffects on cell activities, such as cell growth arrest 
[1] and programmed cell death [2]. In this study, a rapid increase 
of short-chain Cer cerebrosides was observed upon addition of 
short-chain Cer at 5-25/zM, although the synthesis of short- 
chain Cer GM3 was relatively slow at the same concentration 
(Fig. 3B). This may indicate the presence of a novel detoxifica- 
tion mechanism in B16 cells, i.e. in order to reduce the intracel- 
lular concentration of short-chain Cer, they might be quickly 
glycosylated and thus transported to the plasma membrane. 
This is reminiscent of a report indicating that exogenously 
added psychosine (GalSph) was quickly converted to GalCer 
in neuroblastoma cells to exclude the lyso-forms [15]. 
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